Zobrazeno 1 - 10
of 310
pro vyhledávání: '"Razzaque Ahmed, A."'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundPemphigus foliaceus (PF) differs from pemphigus vulgaris (PV) in that it affects only the skin and mucous membranes are not involved. Pemphigus is commonly treated with systemic corticosteroids and immunosuppressive agents (ISAs). More rece
Externí odkaz:
https://doaj.org/article/477040a3f0564dccacd085c04051e092
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Pemphigoid (Pg) diseases are a group of potentially fatal autoimmune mucocutaneous diseases. They have different clinical phenotypes, involving only the skin or multiple mucous membranes. They occur globally and frequently affect the elderly. The com
Externí odkaz:
https://doaj.org/article/b52c045bcc4c4825ab3c77e2f75ac239
Autor:
A. Razzaque Ahmed, Merve Aksoy
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
IgM deficiency has been reported in patients with many autoimmune diseases treated with Rituximab (RTX). It has not been studied, in detail, in autoimmune mucocutaneous blistering diseases (AIMBD). Our objectives were: (i) Examine the dynamics of IgM
Externí odkaz:
https://doaj.org/article/9040f29710c24bb0baf7df6ebfd9d335
Autor:
Khalaf Kridin, A. Razzaque Ahmed
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The many clinical aspects of anti-p200 pemphigoid are not well-characterized. We aimed to analyze and correlate known existing data on the epidemiological, clinical, histological, and immunological features of anti-p200 pemphigoid. We performed a rev
Externí odkaz:
https://doaj.org/article/0a4a4374704a4d10a901ba40c3f6110c
Autor:
A. Razzaque Ahmed, Srinivas Kaveri
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
In this concept paper, the authors present a unique and novel protocol to treat autoimmune diseases that may have the potential to reverse autoimmunity. It uses a combination of B cell depletion therapy (BDT), specifically rituximab (RTX) and intrave
Externí odkaz:
https://doaj.org/article/75bdd91df87f41e49ddadee34ace244c
Publikováno v:
Autoimmunity reviews. 21(8)
Mucous Membrane Pemphigoid (MMP) is a potentially fatal mucocutaneous autoimmune blistering disease. Autoantibodies are produced against various components of the dermo-epidermal or mucosal-submucosal junction are referred to as basement membrane zon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab21085c180f3a2a033bb8bc3e6df5bc
https://pubmed.ncbi.nlm.nih.gov/35688385
https://pubmed.ncbi.nlm.nih.gov/35688385
Autor:
Anna J. Nichols, Samantha C. Gordon, David Rosmarin, Rana Abdat, Michael McLeod, Reid A. Waldman, Brett A. King, Annette Czernik, Valeria De Bedout, Marti J. Rothe, Razzaque Ahmed
Publikováno v:
Journal of the American Academy of Dermatology. 83:46-52
Background Bullous pemphigoid (BP) is an autoimmune blistering disorder occurring mostly in the elderly that lacks adequate treatments. Objective To describe our experience using dupilumab in a series of patients with BP. Methods This is a case serie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afa799196d100a2d4da9a60e67c3cb03
https://doi.org/10.1016/j.jaad.2020.01.089
https://doi.org/10.1016/j.jaad.2020.01.089
Autor:
Merve Aksoy, A. Razzaque Ahmed
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
IgM deficiency has been reported in patients with many autoimmune diseases treated with Rituximab (RTX). It has not been studied, in detail, in autoimmune mucocutaneous blistering diseases (AIMBD). Our objectives were: (i) Examine the dynamics of IgM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::544eaed3ec375f436c9bf403fd8738cb
http://europepmc.org/articles/PMC8504479
http://europepmc.org/articles/PMC8504479
Publikováno v:
Autoimmunity Reviews. 21:103180
This review of Pemphigoid of the Pulmonary System (POPS) is a comprehensive description of pulmonary involvement in patients with mucous membrane pemphigoid (MMP), which is an orphan autoimmune blistering disease. The objective of the review was to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc440a18ba07dcf069f3d6bd33da7304
https://doi.org/10.1016/j.autrev.2022.103180
https://doi.org/10.1016/j.autrev.2022.103180
Autor:
A. Razzaque Ahmed, Khalaf Kridin
Publikováno v:
Expert opinion on biological therapy. 21(4)
Pemphigus vulgaris (PV) is a life-threatening autoimmune mucocutaneous blistering disease. Systemic corticosteroids (CS), while life-saving, have several serious side effects. To improve treatment and prognosis, recently rituximab (RTX), a chimeric m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356c2858c227a036f1d2f7e782e1ebd1
https://pubmed.ncbi.nlm.nih.gov/33455475
https://pubmed.ncbi.nlm.nih.gov/33455475